Search research articles
Contact Us
Filters
Showing results (1-10 of 35) with videos related to
Page
of 4
Sort By:
The EMBO Journal
|
October 17, 2019
Role reversal: adaptive immunity instructs inflammasome activation for anti-viral defence
Rebecca C Coll
Nature Reviews. Immunology
|
December 5, 2024
Author Correction: Inflammasome components as new therapeutic targets in inflammatory disease
Rebecca C Coll, Kate Schroder
Nature Reviews. Immunology
|
December 5, 2024
Publisher Correction: Inflammasome components as new therapeutic targets in inflammatory disease
Rebecca C Coll, Kate Schroder
Nature Reviews. Immunology
|
September 9, 2024
Inflammasome components as new therapeutic targets in inflammatory disease
Rebecca C Coll, Kate Schroder
Cell
|
December 23, 2021
Caging NLRP3 tames inflammasome activity
Kate Schroder, Rebecca C Coll
Journal of Leukocyte Biology
|
August 4, 2020
NLRP3 inflammasome priming: A riddle wrapped in a mystery inside an enigma
Chloe M McKee, Rebecca C Coll
Journal of Innate Immunity
|
May 28, 2010
New insights into the regulation of signalling by toll-like receptors and nod-like receptors
Rebecca C Coll, Luke A J O'Neill
Trends in Pharmacological Sciences
|
May 6, 2022
NLRP3 and pyroptosis blockers for treating inflammatory diseases
Rebecca C Coll, Kate Schroder, Pablo Pelegrín
Immunity
|
December 20, 2018
NLRC3 Restrains Responses to a T
Caroline L Holley, Rebecca C Coll, Kate Schroder
Cell Research
|
November 24, 2018
Author Correction: Mitochondrial DNA synthesis fuels NLRP3 inflammasome
Rebecca C Coll, Caroline L Holley, Kate Schroder
Page
of 4
Search research articles
Search
Showing results (1-10 of 35) with videos related to
Sort By:
Page
of 4
The EMBO Journal
|
October 17, 2019
Role reversal: adaptive immunity instructs inflammasome activation for anti-viral defence
Rebecca C Coll
Nature Reviews. Immunology
|
December 5, 2024
Author Correction: Inflammasome components as new therapeutic targets in inflammatory disease
Rebecca C Coll, Kate Schroder
Nature Reviews. Immunology
|
December 5, 2024
Publisher Correction: Inflammasome components as new therapeutic targets in inflammatory disease
Rebecca C Coll, Kate Schroder
Nature Reviews. Immunology
|
September 9, 2024
Inflammasome components as new therapeutic targets in inflammatory disease
Rebecca C Coll, Kate Schroder
Cell
|
December 23, 2021
Caging NLRP3 tames inflammasome activity
Kate Schroder, Rebecca C Coll
Journal of Leukocyte Biology
|
August 4, 2020
NLRP3 inflammasome priming: A riddle wrapped in a mystery inside an enigma
Chloe M McKee, Rebecca C Coll
Journal of Innate Immunity
|
May 28, 2010
New insights into the regulation of signalling by toll-like receptors and nod-like receptors
Rebecca C Coll, Luke A J O'Neill
Trends in Pharmacological Sciences
|
May 6, 2022
NLRP3 and pyroptosis blockers for treating inflammatory diseases
Rebecca C Coll, Kate Schroder, Pablo Pelegrín
Immunity
|
December 20, 2018
NLRC3 Restrains Responses to a T
Caroline L Holley, Rebecca C Coll, Kate Schroder
Cell Research
|
November 24, 2018
Author Correction: Mitochondrial DNA synthesis fuels NLRP3 inflammasome
Rebecca C Coll, Caroline L Holley, Kate Schroder
Page
of 4